Rampart Skin Graft: Clinical Guide for Wound Care Clinicians

Practical protocol for selecting, applying, and documenting amniotic membrane skin grafts.

By: NextGen Biologics Clinical Education  |  Published: July 11, 2026  |  Category: Wound Care

Chronic wounds are among the most resource-intensive conditions managed in outpatient wound centers, hospital clinics, and surgical practices. Effective care depends on accurate assessment, meticulous wound-bed preparation, and timely escalation to advanced therapies when conventional dressings plateau. The Rampart Skin Graft from NextGen Biologics is a human amniotic membrane-derived skin substitute used for complex wounds that require an extracellular matrix scaffold.

This guide translates the core principles of wound care into a practical protocol for wound care physicians, podiatrists, orthopedic surgeons, and wound center coordinators. It is grounded in the peer-reviewed references listed below and does not introduce data or statistics from outside sources.

What the Evidence Says About Wound Bed Preparation and Skin Integrity

The foundation of advanced wound therapy is a properly prepared wound bed. Cox (2019) outlines the core components of wound care as assessment, cleansing, debridement, moisture balance, and protection of the periwound skin.[3] Carlin AS (2022) emphasizes that structured assessment of impaired skin integrity is essential for selecting an appropriate intervention and monitoring progress.[1] Powers JG et al. (2016) frame chronic wound management around correcting underlying pathophysiology, controlling bioburden, and addressing the patient’s systemic risk factors.[2]

These references do not evaluate the Rampart Skin Graft specifically. They establish the clinical conditions under which any skin substitute is most likely to succeed: a clean, perfused, well-debrided wound bed with controlled edema and infection.

Clinical Pearl: Before applying an advanced biologic, confirm that standard therapy has been optimized and that the wound bed is free of devitalized tissue and unresolved infection. Skin integrity assessment is not a one-time event; it should be repeated at every visit.

When to Consider a Skin Graft in the Wound Care Pathway

A skin substitute should be considered only after standard of care has been optimized and the wound has demonstrated inadequate progress. Practical prerequisites include a reasonable trial of appropriate conservative management, confirmed adequate arterial perfusion, infection control, offloading or pressure redistribution, and optimization of comorbidities such as diabetes and malnutrition.

Special populations require extra judgment. In older adults, skin fragility, moisture-associated skin damage, and polypharmacy can alter the wound trajectory and must be factored into the treatment plan.[5] In oncology patients, radiation injury, immunosuppression, and altered healing from chemotherapy require similar individualized decision-making.[6] The decision to apply Rampart is therefore clinical and individualized, not based on diagnosis alone.

Clinical Protocol for Applying Rampart

  1. Assessment. Measure wound dimensions, depth, undermining, tunneling, exudate, signs of bioburden, and periwound skin condition.[1][3] Document baseline photography and quantitative wound measurements.
  2. Cleansing. Use a non-cytotoxic cleanser appropriate to the wound bed and periwound skin. Milne J (2019) emphasizes that skin cleansing preserves barrier function and supports the wound environment.[4]
  3. Debridement. Remove non-viable tissue to expose a viable wound bed. Maintain hemostasis before graft placement.[2]
  4. Application. Follow the manufacturer’s Instructions for Use (IFU). Hydrate the wound bed if needed, place the graft with the matrix side in contact with the wound bed, ensure full contact, and secure with a non-adherent dressing.
  5. Dressing and offloading. Choose a secondary dressing that manages exudate without macerating periwound skin. Offload pressure areas and immobilize shear-prone sites.
  6. Reassessment. At each visit, re-measure and photograph the wound. Document qualitative or quantitative changes in granulation tissue, epithelialization, exudate, and pain. Continue or discontinue therapy based on response.

Comparison: Amniotic Membrane Skin Grafts vs. Standard Dressings

Feature Rampart Skin Graft Standard Moisture-Retentive Dressings
Primary mechanism Provides an extracellular matrix scaffold to support wound-bed remodeling Maintains a moist environment and manages exudate
Typical candidates Complex or chronic wounds that have not progressed after optimized conservative care Partial-thickness wounds, low-to-moderate exudate wounds, and maintenance-phase wounds
Visit frequency Determined by wound response, dressing choice, and payer medical-necessity criteria Determined by dressing capacity and exudate level
Documentation needs Wound measurements, prior care, medical necessity, graft lot number, and response Wound characteristics, dressing changes, and response

Documentation and Coding Considerations

Accurate documentation protects both the patient and the practice. For each application, record the medical-necessity rationale, prior conservative care, wound characteristics, graft size applied, lot number, application date, and patient response. Payers often require detailed wound measurements and evidence of failure to progress before authorizing advanced biologics.

For billing, report the appropriate skin substitute application code and the corresponding HCPCS Q-code for the product, ensuring that ICD-10-CM codes support the underlying etiology. Coverage policies and fee schedules change frequently; verify current coding guidance on the official CMS website rather than relying on recalled rates.

Operational Reminder: Assign a dedicated coordinator to track prior-authorization requirements, lot numbers, and patient follow-up intervals. This reduces claim denials and helps demonstrate medical necessity at audit.

Key Takeaways

  • Systematic assessment and wound-bed preparation are prerequisites for any advanced therapy.
  • Rampart is considered after optimized standard care has stalled, not as a first-line dressing.
  • Cleansing and debridement should be non-cytotoxic and tissue-preserving where appropriate.
  • Documentation must link the graft to medical necessity and prior wound care.
  • Billing requires accurate Q-code and application code reporting supported by current payer guidance.

Evaluate Rampart in Your Wound Center

Ready to see how Rampart fits your complex wound protocol? Request samples of AmnioAMP or Rampart at nextgenbiologicsusa.com/request-samples.

References

  1. Carlin AS. Essentials of wound care: assessing and managing impaired skin integrity. Nurs Stand. 2022. PMID: 36093637. https://pubmed.ncbi.nlm.nih.gov/36093637/
  2. Powers JG, et al. Wound healing and treating wounds: Chronic wound care and management. J Am Acad Dermatol. 2016. PMID: 26979353. https://pubmed.ncbi.nlm.nih.gov/26979353/
  3. Cox J. Wound Care 101. Nursing. 2019. PMID: 31568079. https://pubmed.ncbi.nlm.nih.gov/31568079/
  4. Milne J. The importance of skin cleansing in wound care. Br J Nurs. 2019. PMID: 31242107. https://pubmed.ncbi.nlm.nih.gov/31242107/
  5. Reddy M. Skin and wound care: important considerations in the older adult. Adv Skin Wound Care. 2008. PMID: 18769169. https://pubmed.ncbi.nlm.nih.gov/18769169/
  6. McNees P. Skin and wound assessment and care in oncology. Semin Oncol Nurs. 2006. PMID: 16893742. https://pubmed.ncbi.nlm.nih.gov/16893742/